A Study to assess and compare effects of Ranibizumab and Aflibercept in Patients with Naive Diabetic Macular Edema in Presence of Serous Retinal Detachment
Latest Information Update: 04 Nov 2020
Price :
$35 *
At a glance
- Drugs Aflibercept (Primary) ; Ranibizumab (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 04 Nov 2020 New trial record